|
Index of reports
> Life Threatening Events (19)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in 58 year old female
Reported by a physician from Taiwan, Province of China on 2012-07-24
Patient: 58 year old female, weighing 57.3 kg (126.1 pounds)
Reactions: Multi-Organ Failure, Pneumonia, Coagulopathy, Central Nervous System Lesion, Acute Respiratory Distress Syndrome, Neutropenia, Acute Respiratory Failure, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Start date: 2010-12-28
End date: 2010-12-28
Taxotere
Indication: Breast Cancer
Start date: 2010-09-30
End date: 2010-09-30
Taxotere
Start date: 2010-12-28
End date: 2010-12-28
Epirubicin
Indication: Breast Cancer
Start date: 2010-09-30
End date: 2010-09-30
Other drugs received by patient: Granocyte
Possible Epirubicin side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23
Patient: 48 year old female
Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-06
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-27
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Possible Epirubicin side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-20
Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Neutropenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Ifosfamide
Start date: 2012-05-17
End date: 2012-05-18
Mesna
Start date: 2012-05-17
End date: 2012-05-18
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Possible Epirubicin side effects in 63 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20
Patient: 63 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Cyclophosphamide
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Fluorouracil
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Possible Epirubicin side effects in 71 year old female
Reported by a consumer/non-health professional from Japan on 2012-06-26
Patient: 71 year old female, weighing 75.0 kg (165.0 pounds)
Reactions: Acute Monocytic Leukaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Fluorouracil
Dosage: twice every 3 weeks x 4 courses
Indication: Breast Cancer
Start date: 2010-09-22
End date: 2010-11-25
Cyclophosphamide
Dosage: twice every 3 weeks x 4 courses
Indication: Breast Cancer
Start date: 2010-09-22
End date: 2010-11-25
Paclitaxel
Dosage: weekly x 12 courses
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-09-15
Paraplatin
Dosage: auc 5 every 3 weeks x 4 courses
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-09-15
Epirubicin
Dosage: twice every 3 weeks x 4 courses
Indication: Breast Cancer
Start date: 2010-09-22
End date: 2010-11-25
Possible Epirubicin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-15
Patient: male
Reactions: Metastases To Adrenals, Neuroblastoma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Start date: 2007-01-01
End date: 2007-01-01
Cyclophosphamide
Start date: 2007-01-01
End date: 2007-01-01
Fluorouracil
Start date: 2007-01-01
End date: 2007-01-01
Possible Epirubicin side effects in female
Reported by a individual with unspecified qualification from Germany on 2012-06-07
Patient: female
Reactions: Vomiting, Nausea, Inappropriate Antidiuretic Hormone Secretion, Coma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Start date: 2012-04-16
End date: 2012-04-16
Cyclophosphamide
Indication: Breast Cancer
Start date: 2012-04-16
End date: 2012-04-16
Other drugs received by patient: Prednisone TAB; Dexamethasone; Sodium Chloride; Aprepitant; Mesna; Granisetron; Hydroxychloroquine Sulfate
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30
Patient: 49 year old female
Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Vincristine
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cyclophosphamide
Dosage: 100 mg
Administration route: Oral
Indication: Anaemia
Prednisolone
Indication: Leukocytosis
Fluorouracil
Indication: Breast Cancer
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cyclophosphamide
Indication: Breast Cancer
Cyclophosphamide
Indication: Leukocytosis
Start date: 2009-07-01
Epirubicin
Indication: Breast Cancer
Prednisolone
Dosage: 15 mg
Indication: Anaemia
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Possible Epirubicin side effects in female
Reported by a physician from France on 2012-05-14
Patient: female
Reactions: Acute Pulmonary Oedema, Cardiac Failure, Hypotension, Tachycardia, Respiratory Distress
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2008-01-01
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-09-06
End date: 2011-09-19
Cyclophosphamide
Start date: 2011-06-01
End date: 2011-08-01
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2011-06-01
End date: 2011-08-01
Epirubicin
Indication: Breast Cancer
Other drugs received by patient: Carvedilol; Dobutamine HCL
Possible Epirubicin side effects in male
Reported by a physician from Poland on 2012-04-16
Patient: male, weighing 102.0 kg (224.4 pounds)
Reactions: Tumour Lysis Syndrome, Renal Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epirubicin
Dosage: 100
Indication: Gastric Cancer
Start date: 2012-01-26
Capecitabine
Dosage: 1361
Indication: Gastric Cancer
Cisplatin
Dosage: 120
Indication: Gastric Cancer
Other drugs received by patient: Dexaven (Dexamethasone Sodium Phosphate); Setronon; Mannitol
Possible Epirubicin side effects in 66 year old female
Reported by a individual with unspecified qualification from Japan on 2012-04-10
Patient: 66 year old female
Reactions: Acute Myeloid Leukaemia, Pancytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Capecitabine
Start date: 2007-06-01
End date: 2007-09-01
Epirubicin
Indication: Breast Cancer
Start date: 2006-08-01
End date: 2007-02-01
Taxotere
Indication: Breast Cancer
Start date: 2006-08-01
Cyclophosphamide
Indication: Breast Cancer
Start date: 2006-08-01
End date: 2007-02-01
Toremifene
Start date: 2007-10-01
End date: 2008-03-01
Anastrozole
Indication: Breast Cancer
Start date: 2008-04-01
End date: 2008-10-01
Taxotere
Start date: 2006-11-09
End date: 2007-01-11
Fluorouracil
Indication: Breast Cancer
Start date: 2006-08-01
End date: 2007-02-01
Letrozole
Indication: Breast Cancer
Start date: 2007-02-01
Capecitabine
Indication: Breast Cancer
Start date: 2007-03-01
End date: 2007-05-01
Toremifene
Indication: Breast Cancer
Start date: 2007-06-01
End date: 2007-09-01
TS-1
Indication: Breast Cancer Metastatic
Start date: 2008-10-01
End date: 2011-06-01
Cyclophosphamide
Start date: 2007-03-01
End date: 2007-05-01
Possible Epirubicin side effects in 50 year old female
Reported by a physician from Mexico on 2012-03-30
Patient: 50 year old female, weighing 65.5 kg (144.1 pounds)
Reactions: Interstitial Lung Disease
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Taxotere
Start date: 2012-01-18
End date: 2012-01-18
Taxotere
Start date: 2012-02-09
End date: 2012-02-09
Taxotere
Start date: 2012-01-18
End date: 2012-01-18
Taxotere
Start date: 2012-02-09
End date: 2012-02-09
Cyclophosphamide
Dosage: 3 cycles.
Taxotere
Start date: 2012-01-18
End date: 2012-01-18
Taxotere
Start date: 2012-03-09
End date: 2012-03-09
Fluorouracil
Dosage: 3 cycles.
Taxotere
Start date: 2012-02-09
End date: 2012-02-09
Taxotere
Start date: 2012-03-09
End date: 2012-03-09
Taxotere
Start date: 2012-03-09
End date: 2012-03-09
Epirubicin
Dosage: 3 cycles.
Possible Epirubicin side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-21
Patient: 56 year old female
Reactions: Myocardial Infarction
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Fluorouracil
Indication: Breast Cancer
Start date: 2003-12-01
End date: 2004-04-01
Cyclophosphamide
Indication: Breast Cancer
Start date: 2003-12-01
End date: 2004-04-01
Epirubicin
Indication: Breast Cancer
Start date: 2003-12-01
End date: 2004-04-01
Possible Epirubicin side effects in male
Reported by a physician from Poland on 2012-03-19
Patient: male, weighing 102.0 kg (224.4 pounds)
Reactions: Tumour Lysis Syndrome, Renal Failure
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cisplatin
Dosage: 120
Indication: Gastric Cancer
Capecitabine
Dosage: 1361
Indication: Gastric Cancer
Epirubicin
Dosage: 100
Indication: Gastric Cancer
Start date: 2012-01-26
Other drugs received by patient: Mannitol; Dexaven (Dexamethasone Sodium Phosphate); Setronon
Possible Epirubicin side effects in female
Reported by a physician from France on 2012-02-27
Patient: female
Reactions: Acute Pulmonary Oedema, Cardiac Failure, Hypotension, Tachycardia, Respiratory Distress
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-09-06
End date: 2011-09-19
Epirubicin
Indication: Breast Cancer
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2011-06-01
End date: 2011-08-01
Other drugs received by patient: Cyclophosphamide; Dobutamine HCL; Carvedilol
Possible Epirubicin side effects in female
Reported by a physician from France on 2012-01-27
Patient: female
Reactions: Acute Pulmonary Oedema, Cardiac Failure, Hypotension, Tachycardia, Respiratory Distress
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Xeloda
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-09-06
End date: 2011-09-19
Doxorubicin HCL
Indication: Breast Cancer
Start date: 2011-06-01
End date: 2011-08-01
Other drugs received by patient: Cyclophosphamide; Carvedilol; Dobutamine HCL
Possible Epirubicin side effects in 66 year old female
Reported by a physician from Japan on 2012-01-04
Patient: 66 year old female, weighing 78.0 kg (171.6 pounds)
Reactions: Acute Myeloid Leukaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epirubicin
Dosage: dosage is uncertain.
Indication: Breast Cancer Metastatic
Start date: 2006-08-11
Xeloda
Dosage: dosage is uncertain.
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-03-01
End date: 2007-05-01
Cyclophosphamide
Dosage: dosage is uncertain.
Start date: 2007-03-01
End date: 2007-05-01
Xeloda
Dosage: dosage is uncertain.
Administration route: Oral
Start date: 2007-06-01
End date: 2007-09-01
Cyclophosphamide
Dosage: dosage is uncertain.
Indication: Breast Cancer Metastatic
Start date: 2006-08-11
Other drugs received by patient: Docetaxel (AS Comparator); Toremifene; Fluorouracil; Femara; Toremifene; Calcium Lactate; Urso 250
Possible Epirubicin side effects in 35 year old female
Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-19
Patient: 35 year old female
Reactions: Drug Hypersensitivity, Maternal Exposure Before Pregnancy, Pregnancy, Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Fluorouracil
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Paclitaxel
Dosage: x1
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Possible Epirubicin side effects in 42 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-06
Patient: 42 year old female, weighing 86.0 kg (189.2 pounds)
Reactions: Intracranial Venous Sinus Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Aranesp
Indication: Breast Cancer
Start date: 2007-06-14
End date: 2007-08-24
Granisetron
Dosage: on day 0 to 3
Administration route: Oral
Indication: Prophylaxis
Start date: 2007-06-13
End date: 2007-09-30
Taxol
Dosage: 40 mg/m2 (09-aug-2007 to 27-sep-2007), weekly.
Indication: Breast Cancer
Start date: 2007-08-09
End date: 2007-10-10
Cyclophosphamide
Indication: Breast Cancer
Start date: 2007-06-14
End date: 2007-07-26
Dexamethasone
Dosage: daily on day 1 to 4, 4mg (13-jun-2007 to 30-sep-2007).
Indication: Prophylaxis
Ranitidine
Dosage: 1 df= 50 units nos, once a day on day 1
Indication: Antiallergic Therapy
Epirubicin
Indication: Breast Cancer
Start date: 2007-06-14
End date: 2007-07-26
Capecitabine
Dosage: 500 mg/m2 (09-aug-2007 to 27-sep-2007), twice daily.
Administration route: Oral
Indication: Breast Cancer
Start date: 2007-08-09
End date: 2007-10-10
Other drugs received by patient: Ibuprofen
|
